Johnson & Johnson Medical Devices — Percent Change (as a percent) decreased by 9.8% to $0.21 in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 19.1%, from $0.26 to $0.21. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive growth indicates expanding market share or increased demand; negative growth suggests market headwinds.
Measures the period-over-period growth rate of the MedTech segment's revenue. It provides a normalized view of performan...
Standard performance indicator used by investors to track segment momentum.
jnj_segment_medtech_percent_change_as_a_percent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.30 | $0.77 | $0.15 | $0.00 | $0.15 | $0.05 | $0.11 | $0.38 | $0.47 | $0.23 | $0.16 | $0.26 | $0.16 | $0.24 | $0.21 |
| QoQ Change | — | +154.6% | -81.3% | -100.0% | — | -67.5% | +120.4% | +248.1% | +25.0% | -51.1% | -32.2% | +67.9% | -37.4% | +43.3% | -9.8% |
| YoY Change | — | — | — | — | -50.3% | -93.7% | -25.5% | +149.0% | +859.2% | — | -58.5% | -44.3% | -28.7% | +50.6% | -19.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.